NCT04662294
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT04603872
- Conditions
- Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory, Blood Protein Disorders, +28 more
- Locations
-
- The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China
NCT04025450
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China
NCT03966443
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Oslo University Hosptal Oslo, Norway
NCT03196414
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China
Recruiting
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT03562169
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Aberdeen Royal Infirmary Aberdeen, United Kingdom
- Monklands Hospital Airdrie, United Kingdom
- University Hospital Ayr Ayr, United Kingdom
- Barnsley Hospital Barnsley, United Kingdom
NCT02869555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Enrolling by Invitation
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
NCT03689595
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Enrolling by Invitation
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
NCT05669989
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Washington University- Site Number : 8400001 St Louis, Missouri, United States
- Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
- Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
- Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
Enrolling by Invitation
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
NCT02473757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States